机器人辅助与腹腔镜微创手术治疗I期子宫内膜癌的比较
回顾性比较2006至2016年间单一大规模学术城市医疗实践中461例腹腔镜与566例机器人辅助微创手术(RA-MIS)治疗的I期子宫内膜癌患者,采用倾向评分逆概率加权调整混杂。RA-MIS组无复发生存(HR 1.41,95%CI 1.12-1.77)、总生存(HR 1.39,95%CI 1.06-1.83)和疾病特异性生存(HR 3.51,95%CI 2.19-5.63)均更差。作者认为这些发现支持对RA-MIS长期结局进行前瞻性评估。
要点
- RA-MIS组无复发生存更差(HR 1.41,95%CI 1.12-1.77)
- RA-MIS组总生存更差(HR 1.39,95%CI 1.06-1.83)
- RA-MIS组疾病特异性生存更差(HR 3.51,95%CI 2.19-5.63)
核心结论
- RA-MIS与较差的长期患者结局相关。
- 作者认为该较低风险人群的数据提示相关临床终点可能出现在中期和长期随访窗口内。
- 作者认为这些发现支持对RA-MIS的长期结局进行前瞻性评估。
研究设计与样本
- 回顾性综述,纳入2006年至2016年间在单一大规模学术城市医疗实践中因子宫内膜癌接受腹腔镜或机器人辅助微创手术(RA-MIS)治疗的患者,确保至少5年潜在随访。
- 共纳入1027例患者,其中461例接受腹腔镜,566例接受RA-MIS。
- 采用基于倾向评分的逆概率治疗加权(IPTW)调整组间混杂变量差异,并使用Cox比例风险回归模型调整混杂权重比较总生存和无复发生存。
主要发现
- 研究期间RA-MIS使用稳步增加,导致腹腔镜组平均监测时间更长(中位8.7年 vs 6.3年,p < 0.001)。
- RA-MIS与较差的无复发生存相关(HR 1.41,95%CI 1.12-1.77)。
- RA-MIS与较差的总生存相关(HR 1.39,95%CI 1.06-1.83)。
- RA-MIS组疾病特异性生存也较差(HR 3.51,95%CI 2.19-5.63)。
- 在复发患者中,RA-MIS组首次复发中位时间短于腹腔镜组(16.3个月 vs 28.7个月,p = 0.07)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文为回顾性综述。
- 原文来自单一医疗实践。
- RA-MIS使用增加导致腹腔镜组平均监测时间更长(中位8.7年 vs 6.3年,p < 0.001)。
- 作者结论指出这些发现支持对RA-MIS的长期结局进行前瞻性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recent reports in both cervical and endometrial cancer suggest that minimally invasive surgery (MIS) had an unanticipated negative impact on long-term clinical outcomes, including recurrence and death. Given increasing use of robotic surgery since the LAP2 trial, we sought to compare the intermediate and long-term outcomes between those who underwent robotic surgery or laparoscopy for Stage I endometrial cancer. METHODS: We performed a retrospective review of patients from a single, large, academic, urban practice who underwent either laparoscopic or robot-assisted MIS (RA-MIS) for the treatment of endometrial carcinoma between 2006 and 2016, ensuring at least 5 years of potential follow-up. To adjust for differences in confounding variables between groups, propensity score-based inverse probability of treatment weighting (IPTW) was performed. Overall and recurrence-free survival were compared using Cox proportional hazards regression models adjusting for confounding weights. RESULTS: 1027 patients were included; 461 received laparoscopy and 566 received RA-MIS. RA-MIS use increased steadily during the study window, which resulted in longer mean surveillance in laparoscopy group (median 8.7 years versus 6.3 years, p < 0.001). RA-MIS was associated poorer recurrence-free (HR: 1.41, 95% CI: 1.12, 1.77) and overall survival (HR: 1.39, 95% CI: 1.06, 1.83). Disease-specific survival was also poorer in the RA-MIS group (HR: 3.51, 95% CI: 2.19, 5.63). Among those who recurred, median time to first recurrence was shorter in the RA-MIS group than the laparoscopy group (16.3 vs. 28.7 months, p = 0.07). CONCLUSION: RA-MIS was associated with poorer long-term patient outcomes. Our data in this lower-risk population indicate relevant clinical endpoints may be occurring during intermediate and long-term follow-up windows. These findings support a prospective evaluation of the long-term outcomes of RA-MIS.
引用
- Argenta PA, Mattson J, Rivard CL, et al. Robot-assisted versus laparoscopic minimally invasive surgery for the treatment of stage I endometrial cancer. Gynecol Oncol. 2022. PMID: 35314086. doi:10.1016/j.ygyno.2022.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。